Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank67
3Y CAGR+11.8%
5Y CAGR+39.5%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+11.8%/yr
Annual compound
5Y CAGR
+39.5%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
5.3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$2.73M-43.3%
2024$4.82M-32.2%
2023$7.11M+263.4%
2022$1.96M+2201.2%
2021$85000.00-83.6%
2020$517000.00-65.1%
2019$1.48M-